Riskpilot← Back to searchSign inGet full accessLäkartjänst i Askim AB
ABActiveOrg 5567463319Sten Sturegatan 17Medical specialists activities · NACE 8622Est. 20071-4 employees
Revenue 2025
SEK 1,4M
-11% vs 2024
EBITDA margin
26.3%
-24% vs 2024
Equity ratio
85.2%
Financial strength
Net profit 2025
SEK 225K
-30% vs 2024
| Revenue | SEK 1,4M | -11% |
| EBITDA | SEK 369K | -24% |
| Net profit | SEK 225K | -30% |
| Total assets | SEK 5,3M | -2% |
| Equity | SEK 4,5M | +1% |
| Employees | — | — |
Legal name
Läkartjänst i Askim AB
Org number
5567463319
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
12 december 2007
Share capital
SEK 800 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva läkartjänster, förärva,förvalta och äga fastigheter, förvalta värdepapper samt därmed förenlig verksamhet.
Address
Sten Sturegatan 17
Email
mabobeeriksson@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 510 | 1 616 | 1 207 | 1 575 | 1 402 |
| Staff expenses | — | — | — | — | −728 |
| EBITDA | 604 | 618 | 279 | 488 | 369 |
| Depreciation & amort. | −84 | −81 | −84 | −86 | −86 |
| EBIT | 520 | 537 | 195 | 402 | 282 |
| Net financials | — | 1 | 10 | 5 | 1 |
| Profit before tax | 520 | 537 | 205 | 406 | 284 |
| Tax | −107 | −111 | −42 | −84 | −59 |
| Net profit | 413 | 426 | 163 | 322 | 225 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 100 | 5 059 | 5 145 | 5 367 | 5 252 |
| Equity | 4 139 | 4 365 | 4 328 | 4 450 | 4 475 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 962 | 694 | 817 | 917 | 778 |
| Total debt | 962 | 694 | 817 | 917 | 778 |
EBITDA margin
26.3%
This company
15.8%
Market median
+66% vs market
20212025
Equity ratio
85.2%
This company
38.2%
Market median
+123% vs market
20212025
Return on equity
5.0%
This company
18.4%
Market median
-73% vs market
20212025
Net profit margin
16.0%
This company
8.1%
Market median
+98% vs market
20212025
Asset turnover
0.27×
This company
1.12×
Market median
-76% vs market
20212025
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
GJ Audit | Audit | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Läkartjänst i Askim AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Göran Joachim André | Audit | 0 companies |
| Filip Eriksson | Deputy Board Member | 0 companies |
| Mahboubeh Heidari Eriksson | Board of Directors | 0 companies |
| Max Harry Robert Schwitzgold | Deputy Board Member | 0 companies |